|
KCMF1 protein, human
|
C496223 |
|
|
DSKB-2 compound
|
C496224 |
|
|
figl-1 protein, C elegans
|
C496225 |
|
|
CCR5 Receptor Antagonists
|
D065100 |
[Compounds and drugs that inhibit or block the activity of CCR5 RECEPTORS.
] |
|
Chloride Channel Agonists
|
D065101 |
[A class of drugs that stimulate chloride ion influx through cell membrane channels.
] |
|
Licensed Practical Nurses
|
D065102 |
[Health personnel who do not hold professional degrees or credentials, but have completed training and are licensed to provide routine patient care under the direction of registered nurses and physicians.
] |
|
Cystine Depleting Agents
|
D065104 |
[Compounds and drugs that react with CYSTINE and convert it into a compound that can be more easily metabolized or intracellularly transported. Drugs in this class have been used to treat CYSTINOSIS.
] |
|
Aromatic Amino Acid Decarboxylase Inhibitors
|
D065105 |
[Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism.
] |
|
Demulcents
|
D065106 |
[Compounds that form soothing films on the surface of MUCOUS MEMBRANES. They are generally used as agents to protect the integrity of internal EPITHELIUM.
] |
|
Ornithine Decarboxylase Inhibitors
|
D065108 |
[Substances and drugs that inhibit or block the activity of ORNITHINE DECARBOXYLASE.
] |
|
radafaxine
|
C496215 |
|
|
hydrobupropion
|
C496216 |
|
|
PEGylated tumor necrosis factor alpha receptor 1
|
C496217 |
|
|
6-(4-(4-imidazol-1-ylphenoxy)benzenesulfonyl)-4,5,6,7-tetrahydrofuro(2,3-c)pyridine-5-carboxylic acid
|
C496218 |
|
|
HLA-B*57_03 antigen
|
C496219 |
|
|
4-((3-aminopropionylamido)-3-(2,4-dichlorophenyl)propionyl)-1-(2-((2-thienyl)ethylaminomethyl)phenyl)piperazine
|
C496210 |
|
|
PepA protein, E coli
|
C496211 |
|
|
KIR2DS1 protein, human
|
C496212 |
|
|
heptadepsin, Paenibacillus
|
C496213 |
|
|
4-(4-(3,4-dichlorophenyl)thiazolylamino)benzenesulfonamide
|
C496214 |
|
